US Patent Issued to BIOAPPLICATIONS, INNOVAC on Sept. 1 for "Vaccine composition comprising plant-expressed recombinant zika virus envelope protein and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,887, issued on Sept. 1, was assigned to BIOAPPLICATIONS INC. (Gyeongsangbuk-do, South Korea) and INNOVAC Corp. (Gangwon-do, South Korea).

"Vaccine composition comprising plant-expressed recombinant zika virus envelope protein and preparation method therefor" was invented by Tae-Wook Hahn (Seoul, South Korea), Minna Shin (Gangwon-do, South Korea), Eun-Ju Sohn (Gyeongsangbuk-do, South Korea) and Hyangju Kang (Gyeongsangbuk-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a vaccine composition including, as active ingredients, a recombinant Zika virus envelope protein including an amino acid sequence of SE...